KAHN BROTHERS GROUP INC: GSK position timeline

KAHN BROTHERS GROUP INC held 158,438 GSK shares at 2026-06-30 per its 13F-HR/A filed 2026-08-17.

the latest 13F is the newest step

1. period ended2026-06-30

   13F/A 158,438 shares

   Change vs previous 13F -2,544 shares

   1.31% of the 13F portfolio, value $8,305,319.

   13F-HR/A 0001039565-26-000006 filed by KAHN BROTHERS GROUP INC
   Filed 2026-08-17 (acceptance time not in the bulk data set), ingested 2026-10-06 09:57:27 UTC

   Acceptance time not in the bulk data set (spec §4.2).

2. period ended2026-03-31

   13F 160,982 shares

   Change vs previous 13F -17,714 shares

   1.58% of the 13F portfolio, value $8,884,596.

   13F-HR 0001039565-26-000002 filed by KAHN BROTHERS GROUP INC
   Filed 2026-05-08 (acceptance time not in the bulk data set), ingested 2026-10-06 09:58:43 UTC

   Acceptance time not in the bulk data set (spec §4.2).

3. period ended2025-12-31

   13F 178,696 shares

   Change vs previous 13F -82,141 shares

   1.55% of the 13F portfolio, value $8,763,251.

   13F-HR 0001039565-26-000001 filed by KAHN BROTHERS GROUP INC
   Filed 2026-02-12 (acceptance time not in the bulk data set), ingested 2026-10-07 03:01:36 UTC

   Acceptance time not in the bulk data set (spec §4.2).

4. period ended2025-09-30

   13F 260,837 shares

   Change vs previous 13F -399,035 shares

   2.12% of the 13F portfolio, value $11,257,724.

   13F-HR 0001039565-25-000006 filed by KAHN BROTHERS GROUP INC
   Filed 2025-11-12 (acceptance time not in the bulk data set), ingested 2026-10-07 03:02:25 UTC

   Acceptance time not in the bulk data set (spec §4.2).

5. period ended2025-06-30

   13F 659,872 shares

   Change vs previous 13F not available

   5.09% of the 13F portfolio, value $25,339,084.

   13F-HR 0001039565-25-000005 filed by KAHN BROTHERS GROUP INC
   Filed 2025-08-14 (acceptance time not in the bulk data set), ingested 2026-10-07 18:23:11 UTC

   Acceptance time not in the bulk data set (spec §4.2).